What do pregnant women know about non-steroidal anti-inflammatory drugs?

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 11, 2009, Pages 1034-1038

  Damase Michel, Christine ^a   Christaud, Julie ^a   Berrebi, Alain ^b   Lacroix, Isabelle ^a   Montastruc, Jean Louis ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b Paul Sabatier University   (France)

Author keywords

Knowledge; Non steroidal anti inflammatory drug; Pregnancy; Risk

Indexed keywords

ACETYLSALICYLIC ACID; DEXTROPROPOXYPHENE PLUS PARACETAMOL; IBUPROFEN; NIFLUMIC ACID; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHLOROGLUCINOL;

ADOLESCENT; ADULT; ANALGESIA; ARTICLE; BLEEDING; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INFORMATION; DRUG USE; FEMALE; FRANCE; HEADACHE; HUMAN; INTERVIEW; KNOWLEDGE; LOW DRUG DOSE; MYALGIA; OUTCOME ASSESSMENT; PAIN; PERCEPTION; PREGNANT WOMAN; PRIORITY JOURNAL; RHINOPHARYNGITIS; RISK ASSESSMENT; SAFETY; SELF MEDICATION; STOMACH PAIN; THIRD TRIMESTER PREGNANCY; TOOTH PAIN;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; FETAL DEVELOPMENT; FRANCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NONPRESCRIPTION DRUGS; PATIENT EDUCATION AS TOPIC; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; QUESTIONNAIRES;

EID: 70549109166     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1817     Document Type: Article

References (22)

1. Turner GR, Levin DL. Prostaglandin synthesis inhibition in persistant pulmonary hypertension of the newborn. Clin Perinatol 1984; 11: 581-589. (Pubitemid 14017907)
2. Alano M, Ngougmna E, Ostrea EM, et al. Analysis of non steroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 2001; 107: 519-523. (Pubitemid 32183186)
3. Vd Heidjen AJ, Provoost AP, Nauta J, et al. Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure. Pediatr Res 1988; 24: 644-648. (Pubitemid 18266179)
4. Moïse KJ, Hutha JC, Sharif DS, Ou CN, et al. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med 1988; 319: 327-331. (Pubitemid 18190885)
5. Bavoux F. Toxicité foetale des anti-inflammatoires non steroidiens. Presse Med 1992; 21: 1909-1912. (Pubitemid 23013279)
6. Chacón A, Menéndez Hernando R, Chimenti Camacho CP, et al. Persistent pulmonary hypertension of the newborn following ingestion of nonsteroidal anti-inflammatory drugs during pregnancy. An Pediatr (Barc) 2008; 68: 357-360.
7. Prefumo F, Marasini M, De Biasio P, et al. Acute premature constriction of the ductus arteriosus after maternal self-medication with nimesulide. Fetal Diagn Ther 2008; 24: 35-38. (Pubitemid 352009141)
8. Duneton P. AFSSAPS. Rappel sur la contre indication de tous les AINS à partir du 6ème mois de la grossesse, lettre aux professionnels de santé, 2003. http://agmed.sante.gouv.fr/htm/10/filltrpsc/lp031201.htm
9. Marimbert J. AFSSAPS. Rappel sur la contre indication des AINS à partir du 6ème mois de la grossesse, quelle que soit la voie d' administration, 2009. http://www.afssaps.fr/Infos-de-securite/Lettresaux- professionnels-de-sante/Rappel-sur-la-contre-indication-des-AINSa- partir-du-debut-du-6eme-mois-de-la-grossesse-quelle-que-soit-la-voied- administration
10. Bongard V, Ménard-Taché S, Bagheri H, et al. Perception of the risk of adverse drug reactions : differences between health professionals and non health professionals. Br J Clin Pharmacol 2002; 54: 433-436. (Pubitemid 35334958)
11. Maceskova B. Knowledge of patients about OTC drugs as a result of pharmacist-patients consultations. Ceska Slov Farm 2002; 51: 292-296. (Pubitemid 35291314)
12. Lacroix I, Hurault C, Sarramon MF, et al. Prescription of drugs during pregnancy: a study using EFEMERIS*, the new French database. Eur J Pharmacol 2009; in press. http://www.springerlink.com/content/ 87q76g682976v463/fulltext.pdf
13. Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the counter pain relievers: focus on non steroidal anti-inflammatory drugs. J Rheumatol 2005; 32: 2218-2224. (Pubitemid 41587871)
14. Damase-Michel C, Lapeyre-Mestre M, Moly C, et al. Drug use during pregnancy: survey in 250 women consulting at a university hospital. J Gynecol Obstet Biol Reprod 2000; 29: 77-85. (Pubitemid 30114984)
15. Mikou S, Buire AC, Trenque T. Automédication chez la femme enceinte. Thérapie 2008; 63: 415-418.
16. Glover DD, Amonkar M, Rybeck BF, et al. Prescription, over-thecounter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 2003; 188: 1039-1045. (Pubitemid 36530060)
17. Werler MM, Mitchell AA, Hernandez-Diaz S, et al. Use of over-thecounter medications during pregnancy. Am J Obstet Gynecol 2005; 193: 771-777.
18. McKenna L, McIntyre M. What over-the-counter preparations are pregnant women taking? A literature review. Integrative literature reviews and meta-analyses, 2006; 636-645.
19. Damase-Michel C, Vié C, Lacroix I, et al. Drug counselling in pregnancy: an opinion survey of French community pharmacists. Pharmacoepidemiol Drug Saf 2004; 13: 711-715. (Pubitemid 39378280)
20. Hurault C, Lacroix I, Bourrel R, et al. Prescriptions et délivrances d'anti-inflammatoires non stéroïdiens après le 6ème mois de grossesse: impact d'une lettre d'information envoyée par les autorités de santé. Presse Med 2008; 37: 767-774.
21. Wen SW, Yang T, Krewski D, et al. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population. J Perinatol 2008; 28: 324-329. (Pubitemid 351622256)
22. Vroom F, Van den Berg PB, De Jong Van den Berg LTW. Prescribing of NSAIDs and ASA during pregnancy; do we need to be more careful? Br J Clin Pharmacol 2007; 65: 275-276.